Advertisement

Topics

Sandoz taps Biocon for biosimilar deal

04:42 EST 18 Jan 2018 | BioPharmaDive

The companies will collaborate on copycat biologics for cancer and immunology. 

Original Article: Sandoz taps Biocon for biosimilar deal

NEXT ARTICLE

More From BioPortfolio on "Sandoz taps Biocon for biosimilar deal"

Quick Search
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Ad Here